Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin, Vitamins and Minerals for COVID-19 and COVID-like Illness
NCT05670444Phase 1Completed
- Sponsor
- Hôpital Universitaire Sahloul
- Start
- Jan 2023
- Primary completion
- Feb 2023
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) and influenza-like illness (ILI), sponsored by Hôpital Universitaire Sahloul. Primary endpoints: Mortality rate at 30 days, Need for ICU admission at 30 days and 1 more. Started Jan 2023; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)influenza-like illness (ILI)
Beyond the preview
Go deeper on NCT05670444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05670444.